Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL4744785 | 1.00 | LMNA (0.39) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| Ammonia Solution, Strong SCHEMBL2015573 | 1.00 | LMNA (0.39) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL92768 | 0.98 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL540415 | 0.98 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL2015790 | 0.98 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL215095 | 0.98 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL14808559 | 0.96 | LMNA (0.39) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL7068618 | 0.93 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL7144047 | 0.93 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL3864585 | 0.93 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109416355-A | Detecting microbial wound infection | 定性酶诊断有限责任两合公司 | 2019-03-01 | — | — | CN | claimed |
| CN-105749289-B | A kind of freeze drying protectant and its application in freeze-dried type attenuated live vaccine for hepatitis A | 中国医学科学院医学生物学研究所 | 2019-01-08 | — | — | CN | claimed |
| CN-107073167-A | The thermogelling composition of sterilizing | 考麦德制药公司 | 2017-08-18 | — | — | CN | claimed |
| EP-3948275-B1 | DIAGNOSTIC FOR CHILDHOOD RISK OF AUTISM SPECTRUM DISORDER | UNIV ARIZONA STATE (US) | 2024-11-13 | — | — | EP | disclosed |
| WO-2024145167-A1 | COMPOSITIONS AND METHODS FOR IMPROVED UTILIZATION OF NON-DIGESTIBLE FIBER IN ANIMALS | ELANCO US INC. (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024113004-A1 | PHARMACEUTICAL COMBINATIONS AND USES THEREOF | THE UNIVERSITY OF MELBOURNE (AU) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024102995-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HUMAN CHLAMYDIAL INFECTIONS AND DISEASES USING ATTENUATED ANIMAL CHLAMYDIA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-05-16 | — | — | WO | disclosed |
| WO-2024086895-A1 | METHODS OF TREATING INSULIN RESISTANCE AND ASSOCIATED DISORDERS | THE UNIVERSITY OF MELBOURNE (AU) | 2024-05-02 | — | — | WO | disclosed |
| WO-2024054707-A2 | LAYER-BY-LAYER DELIVERY OF ACTIVE AGENTS | LUNA LABS USA, LLC (US) | 2024-03-14 | — | — | WO | disclosed |
| EP-4314259-A1 | HYALURONIC ACID-PRODUCING RECOMBINANT CELLS | Givaudan SA (CH) | 2024-02-07 | — | — | EP | disclosed |
| EP-4255357-A1 | DRUG ELUTING STENT | Sino Medical Sciences Technology Inc. (CN) | 2023-10-11 | — | — | EP | disclosed |
| WO-2009011537-A2 | PHYSICAL CONTROL AGENTS AND CONTROL METHOD FROM WATER-SOLUBLE POLYMER AGAINST SMALL-SIZE INSECT PESTS | CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2009-01-22 | — | — | WO | disclosed |
| WO-2008146104-A2 | STABLE LIQUID COMPOSITION OF CHONDROITINSULFATE AND GLUCOSAMINE | HERTEK SA (CH) | 2008-12-04 | — | — | WO | disclosed |
| WO-2008144485-A2 | INHIBITION OF PALMITOYL ACYL TRANSFERASE EXPRESSION AND/OR ACTIVITY FOR THE REGULATION OF ANTIPROLIFERATIVE FACTOR ACTIVITY | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2008-11-27 | — | — | WO | disclosed |
| WO-2008097366-A2 | METABOLICALLY ENGINEERED ESCHERICHIA COLI FOR ENCHANCED PRODUCTION OF SIALIC ACID | SYRACUSE UNIVERSITY (US) | 2008-08-14 | — | — | WO | disclosed |
| WO-2008014484-A1 | CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2008-01-31 | — | — | WO | disclosed |
| CN-1260265-C | Polyhydroxy alkanoate and process for producing them with microbe | CANON KK (JP) | 2006-06-21 | — | — | CN | disclosed |
| CN-1260266-C | Poly(hydroxy alkanoate), its preparation method and use of microbe in its preparation | CANON KK (JP) | 2006-06-21 | — | — | CN | disclosed |
| CN-1322768-A | Polyhydroxy alkanoate and process for producing them with microbe | CANON KK (JP) | 2001-11-21 | — | — | CN | disclosed |
| CN-1321695-A | Poly(hydroxy alkanoate), its preparation method and use of microbe in its preparation | CANON KK (JP) | 2001-11-14 | — | — | CN | disclosed |